Sebök, Martina http://orcid.org/0000-0002-7246-3421
van Niftrik, Christiaan Hendrik Bas
Halter, Matthias
Hiller, Aimee
Seystahl, Katharina
Pangalu, Athina
Weller, Michael
Stippich, Christoph
Regli, Luca
Fierstra, Jorn
Funding for this research was provided by:
Clinical Research Priority Program of the University of Zurich
Swiss National Science Foundation (PP00P3_170683)
Swiss Cancer League (KFS-3975-082016-R)
Article History
First Online: 31 July 2020
Compliance with Ethical Standards
: All the subjects signed an informed consent before they underwent a BOLD-CVR study. The Cantonal Ethics Committee of the Canton Zurich, Switzerland (KEK-ZH-Nr. 2012-0427), approved this study. The study was performed in accordance with the ethical standards as laid down in the 1964 Declaration of Helsinki and its later amendments. Subjects with cerebellar vascular or oncological pathologies or subjects with medical (oncological chemotherapy), radiotherapeutic, or surgical interventions between the BOLD-CVR and FET-PET examination were excluded from further analysis.
: None to report.